Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Immune System Diseases × Rivaroxaban × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Thrombosis 1 Thromboembolism 1 Prostatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Inflammation 1 Immune System Diseases 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

palbociclib 1 Rivaroxaban 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06065592 2023-10-06

CAT_PB

Lebanese University

Phase 1 Unknown

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡